Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
10.24
-0.19 (-1.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Iovance Biotherapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
4 Small-Cap Value Stocks That Could Go Parabolic
May 16, 2024
These four small-cap stocks scan as deeply undervalued right now.
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
May 11, 2024
Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns.
Via
InvestorPlace
Why Iovance Stock Is Down 18% Today
May 10, 2024
Investors are misunderstanding when the biopharma company's flagship drug will begin generating meaningful reportable revenue.
Via
The Motley Fool
Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024
May 09, 2024
IOVA stock results show that Iovance Biotherapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
How Is The Market Feeling About Iovance Biotherapeutics?
May 09, 2024
Via
Benzinga
Is Iovance Biotherapeutics Stock a Buy Now?
April 17, 2024
Let's find out if this biotech can keep up its recent momentum.
Via
The Motley Fool
Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics
March 13, 2024
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
May 05, 2024
The time to jump into a red-hot growth prospect is usually right now...before any more investors identify the opportunity.
Via
The Motley Fool
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
March 01, 2024
Via
Benzinga
Spotlight on Iovance Biotherapeutics: Analyzing the Surge in Options Activity
February 29, 2024
Via
Benzinga
Where Will Iovance Biotherapeutics Stock Be in 5 Years?
April 28, 2024
Is this rising healthcare stock a good buy right now?
Via
The Motley Fool
The Top 3 Biotech Stocks to Buy in April 2024
April 27, 2024
Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances.
Via
InvestorPlace
3 Millionaire-Maker Biotech Stocks
April 25, 2024
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.
Via
The Motley Fool
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
April 21, 2024
Catalysts lie ahead for both of these companies.
Via
The Motley Fool
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
April 05, 2024
These companies are in the early days of their growth stories.
Via
The Motley Fool
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
March 26, 2024
Find out why investment banks up and down Wall Street have big expectations for these stocks.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.
Via
InvestorPlace
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
March 18, 2024
This company's growth story is about to get moving with gusto.
Via
The Motley Fool
Piper Sandler Maintains Overweight Rating for Iovance Biotherapeutics: Here's What You Need To Know
March 14, 2024
Via
Benzinga
Truist Securities Maintains Buy Rating for Iovance Biotherapeutics: Here's What You Need To Know
March 07, 2024
Via
Benzinga
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?
March 07, 2024
Its revenue is set to grow, and one of its trials is no longer paused.
Via
The Motley Fool
Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst
March 06, 2024
With its first approval in hand, attention is now on the top line.
Via
The Motley Fool
Could Iovance Biotherapeutics Stock Help You Become a Millionaire?
March 02, 2024
Does Iovance Biotherapeutics stock possess enough upside to generate life-changing returns for your portfolio?
Via
The Motley Fool
Why Iovance Biotherapeutics Stock Got Trounced on Thursday
February 29, 2024
A robust rally ended abruptly with the publication of the company's latest fundamentals.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?
February 29, 2024
More gains might be on the way for this high-flying biotech stock.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.